Medicare’s Cannabis (CBD) Coverage Plan Sparks Federal Controversy-Is CMS Circumventing FDA Drug Approval Standards? – Morningstar Medicare’s Cannabis (CBD) Coverage Plan Sparks Federal Controversy-Is CMS Circumventing FDA Drug Approval Standards? Morningstar Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest